Forum members respond to the Department of Health & Social Care (DHSC): In support of the Life Sciences Sector Deal 2: Plans for establishing 5 commercial centres for late phase commercial research.
Date: 22 February 2019
The NHS R&D Forum is committed to supporting the Life sciences Industrial strategy and to play our part in the Sector Deal 2, which includes supporting the development of some key initiatives within it. One of these initiatives is the introduction of 5 centres for late phase commercial research, which aim to enable the UK to deliver an ambitious increase in contract clinical research opportunities for patients. Our members and the organisations they represent welcome this.
These 5 centres are expected to provide additional capacity and capability within the NHS/NIHR infrastructure to deliver exceptional service and fast study set up such that the UK is better able to compete for this research. It is hoped once the first 5 are established in England that additional centres will be enabled in the future across the UK.
This paper, written by members, sets out a basic framework of principles aimed at ensuring that this new initiative derives success for all stakeholders and that patients and healthcare research benefit optimally.
Final Forum Response to DHSC – In support of the Life Sciences Sector Deal 2. Implementing the 5 commercial centres Finalversion